ALS Clinical Trial - Safety Study of Oral Edaravone Administered in

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04948645` - A Phase 1 Study to Investigate the Safety and Pharmacokinetics of ABBV-CLS-7262 in Patients With Amyotrophic Lateral Sclerosis	Phase 1
Completed	`NCT02405182` - MRI Biomarkers in ALS
Completed	`NCT00696332` - Talampanel for Amyotrophic Lateral Sclerosis (ALS)	Phase 2
Recruiting	`NCT03865420` - Amyotrophic Lateral Sclerosis (ALS) Families Project
Terminated	`NCT04054141` - rTMS in Treatment of Spasticity	N/A
Recruiting	`NCT03272503` - A Clinical Trial of Pimozide in Patients With Amyotrophic Lateral Sclerosis (ALS)	Phase 2
Completed	`NCT05568615` - Extension Study Following the Studies MT-1186-A03 or A04 to Evaluate the Safety of Oral Edaravone in Subjects With ALS	Phase 3
Recruiting	`NCT05635266` - Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Active, not recruiting	`NCT04259255` - Radicava® (Edaravone) Findings in Biomarkers From ALS (REFINE-ALS)
Recruiting	`NCT02495571` - Assessment of Voluntary and Reflex Cough in Patients With ALS	N/A
Completed	`NCT02525471` - A Pilot Study of RNS60 in Amyotrophic Lateral Sclerosis (ALS)	Phase 1
Recruiting	`NCT05031351` - NF-κB Inhibition in Amyotrophic Lateral Sclerosis	Phase 2
Active, not recruiting	`NCT05581771` - Factors Associated With Success of NIPPV in ALS Patients
Active, not recruiting	`NCT03268603` - Intrathecal Autologous Adipose-derived Mesenchymal Stromal Cells for Amyotrophic Lateral Sclerosis (ALS)	Phase 2
Recruiting	`NCT05271435` - Digital Tools for Assessment of Motor Functions and Falls in ALS
Completed	`NCT06005506` - National Multicenter Interventional Study Aimed at Evaluating the Effect on the Intestinal Microbiota in Chronically Frail Patients Who Share Alterations in Intestinal Function.	N/A
Recruiting	`NCT04138095` - Virtual Reality as an Adjunct to Management of Pain and Anxiety in Palliative Care	N/A
Recruiting	`NCT03698149` - ECoG BMI for Motor and Speech Control	N/A
Not yet recruiting	`NCT05621213` - Satisfaction of Patients With Amyotrophic Lateral Sclerosis Regarding Home Assisted Teleconsultation	N/A
Terminated	`NCT03373981` - Non-invasive Brain Stimulation for the Treatment of Depression Symptoms in ALS	N/A

NCT number	NCT04165824
Study type	Interventional
Source	Mitsubishi Tanabe Pharma America Inc.
Contact
Status	Completed
Phase	Phase 3
Start date	November 18, 2019
Completion date	October 7, 2021

Safety Study of Oral Edaravone Administered in Subjects With ALS

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms